S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

ALGS Aligos Therapeutics Inc

13.05

-0.43 (-3.19%)

08 Mar 2025 - Closed

Delayed by 15 minutes

Form D - Notice of Exempt Offering of Securities

Aligos Therapeutics (NASDAQ:ALGS)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Aligos Therapeutics Charts.

Aligos Therapeutics (NASDAQ:ALGS)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Aligos Therapeutics Charts.

Aligos Therapeutics Inc News

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 5 March 2025 (5 days ago) • Edgar (US Regulatory)

Aligos Therapeutics to Announce 4th Quarter 2024 Financial Results on March 10, 2025
Tuesday 4 March 2025 (6 days ago) • GlobeNewswire Inc.

Form D - Notice of Exempt Offering of Securities
Saturday 1 March 2025 (1 week ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 13 February 2025 (4 weeks ago) • Edgar (US Regulatory)

Aligos Therapeutics Announces $105 Million Private Placement Financing
Wednesday 12 February 2025 (4 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Tuesday 4 February 2025 (1 month ago) • Edgar (US Regulatory)

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Saturday 14 December 2024 (3 months ago) • GlobeNewswire Inc.

Aligos Therapeutics to Present at Investor Conferences in December
Wednesday 27 November 2024 (3 months ago) • GlobeNewswire Inc.

Aligos Therapeutics Presents Positive Data at The Liver Meeting (TLM) 2024
Wednesday 20 November 2024 (4 months ago) • GlobeNewswire Inc.

Form S-3 - Registration statement under Securities Act of 1933
Thursday 7 November 2024 (4 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 7 November 2024 (4 months ago) • Edgar (US Regulatory)

Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2024 Financial Results
Thursday 7 November 2024 (4 months ago) • GlobeNewswire Inc.

More Aligos Therapeutics Inc News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions